Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery

NCT04411615 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04411615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04411615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2020
Completion date
February 28, 2021
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye